Is excisional biopsy indicated for patients with lobular neoplasia diagnosed on percutaneous core needle biopsy of the breast?

American Journal of Surgery

Volumn 198, Issue 6, 2009, Pages 792-797

  Mulheron, Bryan ^a   Gray, Richard J ^a   Pockaj, Barbara A ^a   Apsey, Heidi ^a  

^a MAYO CLINIC   (United States)

Author keywords

Atypical lobular hyperplasia; Breast; Core needle biopsy; Excisional biopsy; Lobular carcinoma in situ; Percutaneous biopsy

Indexed keywords

ARTICLE; BREAST BIOPSY; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; NEEDLE BIOPSY; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 71149119811     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.04.026     Document Type: Article

References (19)

1. Page D.L., Dupont W.D., Rogers L.W., et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55 (1985) 2698-2708
2. Reis-Filho J.S., and Pinder S.E. Non-operative breast pathology: lobular neoplasia. J Clin Pathol 60 (2007) 1321-1327
3. Jacobs T.W., Connolly J.L., and Schnitt S.J. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?. Am J Surg Pathol 26 (2002) 1095-1110
4. Lerwill M.F. The evolution of lobular neoplasia. Adv Anat Pathol 13 (2006) 157-165
5. Sohn V.Y., Arthurs Z.M., Kim F.S., et al. Lobular neoplasia: is surgical excision warranted?. Am Surg 74 (2008) 172-177
6. Brem R.F., Lechner M.C., Jackman R.J., et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol 190 (2008) 637-641
7. Liberman L., Sama M., Susnik B., et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol 173 (1999) 291-299
8. Elsheikh T.M., and Silverman J.F. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29 (2005) 534-543
9. Lavoue V., Graesslin O., Classe J.M., et al. Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. Breast 16 (2007) 533-539
10. El-Sayed M.E., Rakha E.A., Reed J., et al. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 53 (2008) 650-657
11. Cangiarella J., Guth A., Axelrod D., et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?. A report of 38 cases and review of the literature. Arch Pathol Lab Med 132 (2008) 979-983
12. O'Driscoll D., Britton P., Bobrow L., et al. Lobular carcinoma in situ on core biopsy-what is the clinical significance?. Clin Radiol 56 (2001) 216-220
13. Karabakhtsian R.G., Johnson R., Sumkin J., et al. The clinical significance of lobular neoplasia on breast core biopsy. Am J Surg Pathol 31 (2007) 717-723
14. Nagi C.S., O'Donnell J.E., Tismenetsky M., et al. Lobular neoplasia on core needle biopsy does not require excision. Cancer 112 (2008) 2152-2158
15. Chivukula M., Haynik D.M., Brufsky A., et al. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol 32 (2008) 1721-1726
16. Chuba P.J., Hamre M.R., Yap J., et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23 (2005) 5534-5541
17. Page D.L., and Simpson J.F. What is atypical lobular hyperplasia and what does it mean for the patient?. J Clin Oncol 23 (2005) 5432-5433
18. Fisher B., Costantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 90 (1998) 1371-1388
19. Kirstein L.J., Martei Y., Roche C., et al. LCIS and tamoxifen use: a single institution review. J Clin Oncol 25 (2007) 1527